A5056342221- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- COVID-19 Clinical Research Studies
- Acute Myocardial Infarction Research
- Venous Thromboembolism Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Heart Failure Treatment and Management
- Long-Term Effects of COVID-19
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pericarditis and Cardiac Tamponade
- Cardiac Valve Diseases and Treatments
- Sarcoidosis and Beryllium Toxicity Research
- Medical Imaging and Pathology Studies
- Cardiovascular Effects of Exercise
- Cardiac tumors and thrombi
- Acute Ischemic Stroke Management
- Advanced X-ray and CT Imaging
- Takotsubo Cardiomyopathy and Associated Phenomena
- SARS-CoV-2 and COVID-19 Research
- Liver Disease and Transplantation
- Cardiac, Anesthesia and Surgical Outcomes
- Liver Disease Diagnosis and Treatment
- Cardiovascular and exercise physiology
Henry Ford Hospital
2015-2024
Detroit R&D (United States)
2024
Orthopedic Institute
2023
Cleveland Clinic
2023
Henry Ford Health System
2020-2021
Wayne State University
2018
Background Acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is associated with significant morbidity and mortality. Mechanical circulatory support (MCS) devices increase systemic blood pressure end organ perfusion while reducing cardiac filling pressures. Methods Results The National Cardiogenic Shock Initiative (NCT03677180) a single‐arm, multicenter study. purpose of this study was to assess the feasibility effectiveness utilizing early MCS Impella in patients...
Abstract Objectives We applied the cardiovascular angiography and interventions (SCAI) shock staging system to patients presenting with acute myocardial infarction cardiogenic (AMI‐CS) who were enrolled in National Cardiogenic Shock Initiative (NCSI). Background The SCAI provides a framework for evaluation of CS based on clinical hemodynamic parameters, but has not been validated AMI‐CS managed contemporary treatment algorithm that incorporates early use Impella. Methods Consecutive NCSI...
Abstract Background Increasing vasopressor dose is associated with increasing mortality in patients presenting acute myocardial infarction and cardiogenic shock (AMICS). It unknown whether the use of vasopressors independently harmful or if their secondary to decreasing intrinsic cardiac power output (CPO). Mechanical circulatory support (MCS) devices enhance CPO. We sought evaluate independent impact on survival National Cardiogenic Shock Initiative (NCSI). Methods The NCSI a single arm...
Respiratory failure is the most common cause of death in patients with corona virus disease 2019 (COVID-19). There have been many investigations to determine predictors bad outcomes this illness. Liver enzyme elevation has described hospitalized severe COVID-19; however, little known about significance liver injury regarding outcomes. We conducted a retrospective chart review 348 admitted COVID-19 our quaternary care center. on admission was defined based laboratory cutoff aspartate...
Patients presenting with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) are at high risk for impaired antiplatelet activity secondary to malabsorption, systemic hypoperfusion, hypothermia, need mechanical ventilation, and use of analgesics. The therapy in these high-risk patients is not well studied.
Acute myocardial infarction complicated by cardiogenic shock (AMICS) is associated with high mortality. Patients ≥75 years old represent an increasing proportion of those who present AMICS and are at risk for adverse outcomes.The National Cardiogenic Shock Initiative includes patients treated using a standard protocol early invasive hemodynamic monitoring, mechanical circulatory support (MCS), percutaneous coronary intervention (PCI). We evaluated the outcomes based on their age group,...
"Refractory Hypoxemia in Acute-on-Chronic Submassive Pulmonary Embolism." Annals of the American Thoracic Society, 20(11), pp. 1654–1658
Takotsubo cardiomyopathy (TCM) is a form of non-ischemic that can present with signs heart failure and volume overload; it often mimics acute coronary syndrome. It characterized by stress-induced transient left ventricular (LV) dysfunction. Echocardiography classically demonstrates LV apical ballooning akinesis in typical TCM, although other less common variants exist. Patients typically one variant. A 32-year-old woman past medical history alcohol use disorder, anxiety, hypertension...